RT Journal Article
SR Electronic
T1 Characterising People who inject drugs, and association with HIV infection: A Situation Analysis in Kampala city, Uganda
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.05.31.24308282
DO 10.1101/2024.05.31.24308282
A1 Mudiope, Peter
A1 Mathers, Bradley
A1 Nangendo, Joanita
A1 Samuel, Mutyaba
A1 Mutamba, Byamah Brian
A1 Alamo, Stella
A1 Nanyenya, Nicholus
A1 Makumbi, Fredrick
A1 Laker-Oketta, Miriam
A1 Wanyenze, Rhoda
YR 2024
UL http://medrxiv.org/content/early/2024/06/01/2024.05.31.24308282.abstract
AB Background Uganda has implemented targeted interventions to address the rising burden of injection drug use, yet barriers persist in reaching persons who inject drugs (PWID). This study describes the characteristics of people who inject drugs, physical and mental health states, and associated risk behaviors, to inform the designing of programs that are tailored to client’s needs and preferences.Methods A cross-sectional survey was conducted between August and December 2023 at selected hotspots in Kampala, interviewing 499 PWID aged ≥18 years. Data was collected using a semi-structured questionnaire administered by peer educators and Uganda Harm Reduction Network (UHRN) counselors. Measurements included socio-demographics, injecting drug use and sexual risk behaviors, and medical history. HIV serostatus was dtermined by self-report and testing for participants who had no recent history of testing and consented to be tested. Binary logistic regression was used to establish the relationship between HIV infection and risky drug- and sexual behaviors of PWID.Results Participants were predominantly Ugandan (95.2%), male (73.2%), unmarried (55.9%), unemployed (81.8%), with higher levels of education and varying ages. Mental disorders were prevalent, with 48.7% reporting at least one underlying condition, including depression (30.8%) and anxiety (9.6%). Physical health issues were also noted, with reported cases of fever (32.9%), cough (32.5%), malaria (22%) and sexually transmitted infections (STIs) (15%).Regarding drug use patterns, the majority (82.6%) were introduced to drugs by close acquaintances, with 70.9% categorized as people who inject drugs. HIV prevalence among injecting drug users was 3.7%, with higher rates among females (8.4%) and non-Ugandans (16.7%). Being female and experiencing difficulty accessing sterile injection materials were associated with HIV-positive status, highlighting the complex interplay between socio-demographic factors, risk behaviors, and HIV infection among individuals with injecting drug use Disorder in Uganda.Conclusion Our study provides a comprehensive insight into the socio-demographic, mental, physical health, and HIV risk behavoir of PWID in Kampala, Uganda. The findings indicate significant vulnerabilities to injecting drug use, mental disorders, and high-risk behaviors that predispose this population to HIV infection. Despite a low HIV prevalence compared to previous estimates, the interplay between drug use, risky injecting practices, and sexual behaviors suggests an urgent need for targeted interventions to address these intertwined challenges.Competing Interest StatementThe authors have declared no competing interest.Funding StatementResearch reported in this publication was supported by the Fogarty International Center and the United States of America National Institute on Mental Health of the National Institutes of Health under Award Number D43 TW010037. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This evaluation was approved by the Makerere University School of Public Health, Higher degrees Research and Ethics Committee, the Uganda National Council of Science and Technology (UNCST), and the administration of Butabika Hospital.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe datasets analysed during the current study will be shared on reasonable request by the correspondingCHAUCommunity Health Alliance UgandaMOUDmedication for opioid use disorderOUDOpioid use disorderPWIDPeople Who inject drugsIDUInjecting drug userHRNUganda Harm Reduction Network Organization